Prof. Tang Jingyan
Professor · Doctoral Supervisor, Hematology-Oncology
Shanghai Children's Medical Center, SJTUAcademic Profile
Prof. Tang Jingyan is a founding figure of pediatric oncology in China. At Shanghai Children's Medical Center she established the country's first multidisciplinary (MDT) model for pediatric malignant solid tumors and led national collaborative protocols. She is editor-in-chief of the reference textbook 'Diagnosis and Treatment of Pediatric Tumors' and has published over 200 academic papers.
Appointments & Honors
- Immediate Past Chair, Pediatric Oncology Committee, China Anti-Cancer Association
- Director, NHC Key Laboratory for Pediatric Hematology & Oncology; Deputy Head, Hematology Group, Chinese Society of Pediatrics
- Pioneered China's multidisciplinary collaboration model for pediatric solid tumors; 200+ papers (100+ as first/corresponding author)
Appointments
- Professor & Doctoral Supervisor, Hematology-Oncology, Shanghai Children's Medical Center
- Immediate Past Chair, Pediatric Oncology Committee, China Anti-Cancer Association
- Director, NHC Key Laboratory for Pediatric Hematology & Oncology; Deputy Head, Hematology Group, Chinese Society of Pediatrics
Academic Achievements
- Established China's first multidisciplinary (MDT) collaboration model for pediatric malignant solid tumors
- Led national collaborative protocols for pediatric lymphoma and solid tumors (CCCG system)
- Editor-in-Chief of the national reference textbook 'Diagnosis and Treatment of Pediatric Tumors'
- Published 200+ academic papers, 100+ as first or corresponding author
Selected Publications
Diagnosis and Treatment of Pediatric Tumors (national reference textbook)
People's Medical Publishing House · 2017 · Editor-in-Chief
Multidisciplinary collaborative management of pediatric malignant solid tumors: the Shanghai model
Chinese pediatric oncology multicenter series · 2018 · Corresponding author
Risk-adapted therapy for pediatric lymphoma in China: collaborative group experience
Chinese Journal of Pediatric Hematology & Oncology · 2020 · Corresponding author
Areas of Expertise
- Neuroblastoma & Wilms tumor — MDT risk-adapted therapy
- Pediatric lymphoma (Hodgkin & non-Hodgkin)
- Childhood leukemia — standardized protocols
- Histiocytic disorders
Outpatient Schedule
- Tue AM · Special Needs Clinic (Hematology-Oncology)
- Tue AM · Special Needs Clinic (Hematology-Oncology)
- Thu AM · Solid Tumor MDT
Schedules are confirmed with the hospital's international office before your visit. Actual availability is subject to the hospital's same-day announcement.
